Home > Articles > Published articles > Clinical benefit of cancer drugs approved in Switzerland 2010-2019 > Comments
 
 
Clinical benefit of cancer drugs approved in Switzerland 2010-2019 - Adam, Roman (Faculty of Medicine. University of Basel) ; Tibau Martorell, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ; Valiente, C.M. (Institut d'Investigació Biomèdica Sant Pau) ; Šeruga, Bostjan (Univerza V Ljubljani) ; Ocaña, Alberto (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos) ; Amir, Eitan (University of Toronto, Canada) ; Templeton, Arnoud (St. Clara Research Ltd.)
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>

Similar records

UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with